How ultrafine particles and micro‑nano plastics affect fetal development
Official title: UPRISE Unravelling Ultrafine Particulate Matter and Micro Nano Plastic's Mechanisms of Impact on Fetal Health
Run by Instituto de Investigacion Sanitaria La Fe · NCT07238608 · Data updated 2026-11-12
This project will test whether pregnant women’s exposure to ultrafine particulate matter and micro‑nano plastics increases the chance of preterm birth and later non‑communicable diseases in their children.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1600 (estimated) |
| Sponsor | Instituto de Investigacion Sanitaria La Fe Academic / other |
| Locations | 1 site (Valencia, Valencia) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | November 20, 2025 |
| Trial ID | NCT07238608 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non‑smoking pregnant women aged 18 or older who have lived in the study area for at least one year and can enroll early in pregnancy.
✕Probably not a fit
Women who smoke, have multiple pregnancies, known kidney disease, late presentation after the first trimester, or who plan to terminate the pregnancy are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational case‑control study of 1,600 newborns comparing preterm and full‑term births, with a 1:2 control ratio in participating countries. A nested personal exposure monitoring substudy will equip 150 pregnant mothers (50 per location) with sensors to measure individual ultrafine particle and micro‑plastic exposure and collect biological samples including urine. Participants are non‑smoking women aged 18 or older who have lived in the study area at least one year and enroll early in pregnancy; exclusions include multiple pregnancy, known kidney disease, significant pregnancy complications, or late first visit. Data will be used to link measured exposures in pregnancy to timing of delivery and early‑life markers that may predispose to later non‑communicable diseases.
Why it matters
Potential benefit: If successful, the project could identify specific prenatal exposures that raise preterm birth risk and support actions to reduce exposure during pregnancy to improve child health.
How similar studies have gone: Prior epidemiological work has linked general air pollution (PM2.5/PM10) to preterm birth, but the specific roles of ultrafine particles and micro‑nano plastics are less established and personal exposure monitoring in pregnancy remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Agreement to sign the informed consent; * Non-smoking mothers and no exposure to environmental (second-hand) smoke (smoking influences UFP measurements); * ≥18 years old (mothers have to place sensors, mothers with childhood pregnancies may live at their parental home); * Not expecting to terminate the pregnancy (no measurements of the child); * Having resided in the geographical area of research for a minimum period of 1 year (to be eligible for modeling exposures). Exclusion Criteria: * First visit after 11 weeks of gestation (to ensure 2-week monitoring in the first trimester); * Pregnancy complications that limit exposure measurements in urine (because it may cause polyuria, for example, gestational diabetes); * Known kidney disease (might influence exposure measurements in urine); * Multiple pregnancy (twin or more pregnancies may have a higher risk for complications or preterm birth, no measurements in the last trimester).
Where it's running
-
Instituto de Investigación Sanitaria La Fe
Valencia, Valencia, Spain Recruiting
Study contacts
- Study coordinator: Alba Ruiz Gaitán, Dr
- Email: alba_ruiz@externos.iislafe.es
- Phone: 0034961246690
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal yoga to help with birth experience and body image
This study tests whether a prenatal yoga program can improve how pregnant women perceive traumatic birth, how they feel about their bodies, and their preferred delivery method.
-
Preventing abdominal stretch marks in expectant mothers with Stratamark
This program will try Stratamark on pregnant women to see if applying it to the abdomen prevents stretch marks during pregnancy and after birth.
-
Oral health knowledge in pregnant women: does a one-time information leaflet help?
A one-time printed leaflet is tested to see if it improves oral health knowledge in pregnant women attending Hospital La Fe.
-
Outpatient induction of labour with a double‑balloon transcervical catheter for low‑risk pregnant women
This trial will test whether starting cervical ripening at home with a double‑balloon catheter is as safe, acceptable, and time‑efficient as staying in hospital for low‑risk pregnant women due for induction of labour.
-
Using placental blood markers to detect fetal stress during labor
This study will test whether levels of placental markers (sFlt-1, PlGF, and their ratio) can help predict which pregnant people (≥32 weeks) may experience fetal distress during labor.
-
Online psychosocial support for pregnant women after a fetal anomaly diagnosis
This study tests an online psychosocial support program to help pregnant women told their fetus may have an anomaly cope and protect their mental health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.